2023-03-01 07158835 2024-02-28 07158835 2023-03-01 2024-02-28 07158835 2023-02-28 07158835 2022-03-01 2023-02-28 07158835 uk-core:WithinOneYear 2023-02-28 07158835 uk-core:WithinOneYear 2024-02-28 07158835 uk-core:ShareCapital 2024-02-28 07158835 uk-core:ShareCapital 2023-02-28 07158835 uk-core:RetainedEarningsAccumulatedLosses 2024-02-28 07158835 uk-core:RetainedEarningsAccumulatedLosses 2023-02-28 07158835 uk-bus:Director1 2023-03-01 2024-02-28 07158835 uk-core:FurnitureFittings 2023-03-01 2024-02-28 iso4217:GBP 07158835 uk-bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-28 07158835 uk-bus:FRS102 2023-03-01 2024-02-28 07158835 uk-bus:FilletedAccounts 2023-03-01 2024-02-28 07158835 uk-bus:EntityNoLongerTradingButTradedInPast 2023-03-01 2024-02-28 07158835 uk-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28
Pharmacall Limited
Registered Number:07158835
For the year ended 28 February 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 28 February 2024
Pharmacall Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
07158835
As at 28 February 2024
Pharmacall Limited
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
2,074
2,074
2
2,074
2,074
Current assets
46
Cash and cash equivalents
46
46
46
Trade and other payables: amounts falling due within one
year
(1,812)
(1,812)
3
(1,766)
(1,766)
Net current liabilities
Total assets less current liabilities
308
308
308
Net assets
308
Capital and reserves
Called up share capital
100
100
Retained earnings
208
208
308
308
Shareholders' funds
The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 28 February 2024.
The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges her responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Kajal Sahdev Director
These financial statements were approved and authorised for issue by the Board on 11 March 2024 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 28 February 2024
Pharmacall Limited
Notes to the Financial Statements
Statutory Information
Pharmacall Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 07158835.
Registered address:
98 Grosvenor Road
Ilford
Essex
IG1 1LA
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
Revenue recognition
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Property, plant and equipment
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
15% Reducing balance
Fixtures and fittings
Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
2. Property, plant and equipment
Fixtures and
fittings
£
Cost or
valuation
At 01 March 2023
2,750
At 28 February 2024
2,750
Provision for depreciation and impairment
At 01 March 2023
676
At 28 February 2024
676
At 28 February 2024
Net book value
2,074
At 28 February 2023
2,074
2 of 3
5
For the year ended 28 February 2024
Pharmacall Limited
Notes to the Financial Statements Continued
3. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Taxation and social security
137
137
Other creditors
1,675
1,675
1,812
1,812
3 of 3